Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A research consortium in which Professor Anna Gloyn is a member has been awarded EU funding of €5.99 million as part of the Horizon 2020 Research and Innovation Framework Progamme.

The consortium which involves eleven partners will “Develop a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes -T2DSystems”.